The Apollo Therapeutics Fund's Secures £40 Million

Global Legal Chronicle

"The Apollo Therapeutics Fund is a collaboration between AstraZeneca, GlaxoSmithKline and Johnson & Johnson and Imperial Innovations, Cambridge Enterprise and UCL Business, the Technology Transfer Offices (TTOs) responsible for commercialising the research from three leading UK universities, Imperial College London, the University of Cambridge and University College London. Cooley advised the TTOs and was involved in coordinating the transaction."

Read the article here.

Related Contacts
Nicola Maguire Partner, London
John Wilkinson Partner, London